Home
Market Capitalization of Ipca Laboratories Ltd

Ipca Laboratories Ltd
NSE: IPCALAB
Market Cap
Key Highlights
- The Market Cap of Ipca Laboratories Ltd is ₹ 36674 crore as of 21 Feb 25 .
- The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1445 as of 21 Feb 15:30 .
- The Dividend Payouts of Ipca Laboratories Ltd changed from ₹ 8 on Nov 13, 2020 to ₹ 2 on Nov 27, 2024 . This represents a CAGR of -20.63% over 6 years.

Ipca Laboratories Ltd
NSE: IPCALAB
Share Price
Market Price of Ipca Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1445.55 |
20 Feb 2025 | 1497.3 |
19 Feb 2025 | 1469.3 |
18 Feb 2025 | 1470.35 |
17 Feb 2025 | 1475.45 |
14 Feb 2025 | 1461.8 |
13 Feb 2025 | 1491.55 |
12 Feb 2025 | 1420.4 |
11 Feb 2025 | 1419.15 |
10 Feb 2025 | 1445.9 |
SWOT Analysis Of Ipca Laboratories Ltd
BlinkX Score for Ipca Laboratories Ltd
Asset Value vs Market Value of Ipca Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Ipca Laboratories Ltd
Historical P/E Ratio of Ipca Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Ipca Laboratories Ltd
Historical Revenue of Ipca Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Ipca Laboratories Ltd
Historical EBITDA of Ipca Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Ipca Laboratories Ltd
Historical Net Profit of Ipca Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Ipca Laboratories Ltd
Historical Dividend Payouts of Ipca Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Ipca Laboratories Ltd
About Ipca Laboratories Ltd
- Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
- The products of the Company are now sold in over 100 countries across the globe.
- The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.
Ipca Laboratories Ltd News Hub
Ipca Laboratories Ltd soars 2.3%, rises for third straight session
Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs 1416.1, up
Read more
21 Aug 24
Ipca Laboratories consolidated net profit rises 18.07% in the June 2024 quarter
Net profit of Ipca Laboratories rose 18.07% to Rs 192.24 crore in the quarter ended June 2024 as aga
Read more
13 Aug 24
Ipca Laboratories Ltd gains for fifth session
Ipca Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1378.5
Read more
12 Aug 24
Ipca Laboratories Ltd soars 2.1%
Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1368.6
Read more
08 Aug 24